Roy Eldor

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

Aurora Merovci, Carolina Solis‐Herrera, Giuseppe Daniele et al. · Journal of Clinical Investigation · 2014 · 780 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

Ralph A. DeFronzo, Roy Eldor, Muhammad Abdul‐Ghani · Diabetes Care · 2013 · 309 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents

Roy Eldor, Avner Yeffet, Ketty Baum et al. · Proceedings of the National Academy of Sciences · 2006 · 248 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Giuseppe Daniele, Juan Xiong, Carolina Solis‐Herrera et al. · Diabetes Care · 2016 · 210 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial

Richard E. Pratley, Roy Eldor, Annaswamy Raji et al. · Diabetes Obesity and Metabolism · 2017 · 164 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16